Effects of Shape on the Disintegration Time and Friability of Sucroferric Oxyhydroxide-Containing Mini-Tablets
Chemical and Pharmaceutical Bulletin · 29.03.2025 · 73 (3) · 257-263
DOI: 10.1248/cpb.c24-00675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, erschienen am 29.03.2025. Verfasst von Hiroaki Omori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Science, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japa…. Hauptthemen laut MEDLINE: Tablets, Tensile Strength. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice and Science, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.
- Pharmaceutical Research Lab, Kissei Pharmaceutical Co., Ltd., 4365-1 Kashiwabara, Hotaka, Azumino, Nagano 399-8304, Japan.
Zitieren
APA
Omori, H., Kurashima, H., Isshiki, N., Kashiwagura, Y., & Uchida, S. (2025). Effects of Shape on the Disintegration Time and Friability of Sucroferric Oxyhydroxide-Containing Mini-Tablets. Chemical and Pharmaceutical Bulletin, 73(3), 257-263. https://doi.org/10.1248/cpb.c24-00675
Vancouver
Omori H, Kurashima H, Isshiki N, Kashiwagura Y, Uchida S. Effects of Shape on the Disintegration Time and Friability of Sucroferric Oxyhydroxide-Containing Mini-Tablets. Chemical and Pharmaceutical Bulletin. 2025;73(3):257-263. doi:10.1248/cpb.c24-00675
BibTeX
@article{Omori2025,
author = {Omori, Hiroaki and Kurashima, Homare and Isshiki, Nobuyuki and Kashiwagura, Yasuharu and Uchida, Shinya},
title = {Effects of Shape on the Disintegration Time and Friability of Sucroferric Oxyhydroxide-Containing Mini-Tablets},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2025},
volume = {73},
number = {3},
pages = {257--263},
doi = {10.1248/cpb.c24-00675}
}
EUVIMED